St. Francis' titanium implant sales strong

06/5/2006 | American City Business Journals

The FDA's recent approval of St. Francis Medical Technologies' titanium-alloy implant for lumbar spinal stenosis has meant surging U.S. sales for the privately held company. The company's president and CEO said he anticipates worldwide revenue of $30 million to $50 million this year, up from $11 million last year.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Program Manager II
Tufts Health Plan/Network Health
Medford, MA
Director, Medicare Advantage/Medicare Part D Focus
Avalere Health
Washington, DC